Correlation Between Pfizer and TARGET

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and TARGET at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and TARGET into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and TARGET P 7, you can compare the effects of market volatilities on Pfizer and TARGET and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of TARGET. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and TARGET.

Diversification Opportunities for Pfizer and TARGET

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and TARGET is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and TARGET P 7 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TARGET P 7 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with TARGET. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TARGET P 7 has no effect on the direction of Pfizer i.e., Pfizer and TARGET go up and down completely randomly.

Pair Corralation between Pfizer and TARGET

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the TARGET. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.95 times less risky than TARGET. The stock trades about -0.07 of its potential returns per unit of risk. The TARGET P 7 is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  11,356  in TARGET P 7 on October 10, 2024 and sell it today you would earn a total of  988.00  from holding TARGET P 7 or generate 8.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy38.71%
ValuesDaily Returns

Pfizer Inc  vs.  TARGET P 7

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
TARGET P 7 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in TARGET P 7 are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, TARGET sustained solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and TARGET Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and TARGET

The main advantage of trading using opposite Pfizer and TARGET positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, TARGET can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TARGET will offset losses from the drop in TARGET's long position.
The idea behind Pfizer Inc and TARGET P 7 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Correlations
Find global opportunities by holding instruments from different markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio